Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omission of dexamethasone premedication during paclitaxel treatment
NL-OMON60735Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in Nonhematologic neoplasms, sponsored by Erasmus MC. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON60735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60735.